Inogen | INGN - Ebit

Aktienkurs
7.12
Täglich Wechseln
0.07 0.99%
Monatlich
4.71%
Jährlich
-0.70%
Q2 Prognose
6.83




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Accuray USD 11.38M 12.71M 2024-09
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 526K 1.96M 2026-03
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.05B 190M 2026-03
Chart Industries USD 103.3M 74.2M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Insulet USD 122M 24.3M 2026-03
Masimo USD 83.9M 200K 2025-12
Medtronic USD 1.74B 40M 2025-12
Orthofix International USD 6.12M 1.91M 2025-12
Philips EUR 302M 417M 2026-03
ResMed USD 505.67M 8.07M 2026-03
Steris USD 278M 7.1M 2025-12
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 76.31M 2025-12
X T L Biopharmaceuticals USD -479K 19K 2024-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03